Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy. Issue 4 (August 2021)

• Record Type: Journal Article
• Authors: El-Dib, Mohamed; Szakmar, Eniko; Chakkarapani, Ela; Aly, Hany
• Is Part Of: Seminars in fetal & neonatal medicine. Volume 26:Issue 4(2021)
• Publication Date: 2021-08
• Subjects: Mechanical ventilation -- Therapeutic hypothermia -- Hypoxia -- Ischemia -- Sodium bicarbonate -- Caffeine; Neonatology -- Periodicals; Newborn infants -- Diseases -- Periodicals; Fetus -- Diseases -- Periodicals; 618.9201
• DOI: 10.1016/j.siny.2021.101263
• Languages: English
• ISSNs: 1744-165X

Abstract

Abstract: Neonatal encephalopathy (NE) is a serious condition with devastating neurological outcomes that can impact oxygenation and ventilation. The currently recommended therapeutic hypothermia (TH) for these infants may also has several respiratory implications. It decreases metabolic rate and oxygen demands; however, it increases oxygen solubility in the blood and impacts its release to peripheral tissue including the brain. Respiratory management of infants treated with TH should aim for minimizing exposure to hypocapnia or hyperoxia. Inspiratory gas should be heated to 37 °C and humidified to prevent airway and alveolar injury. Blood gas values should be corrected to the core temperature during TH and the use of alkaline buffers is discouraged. While mild sedation/analgesia may ameliorate the discomfort related to cooling, paralytic agents/heavy sedation should be used with caution considering their side effects. Finally, the use of caffeine still needs careful investigation in this population.